Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Heart Failure and Inpatient Outcomes in Multiple Myeloma: A National Inpatient Sample Analysis, 2016-2020

MM - 746

Heart Failure and Inpatient Outcomes in Multiple Myeloma: A National Inpatient Sample Analysis, 2016-2020

Srijani Thannir

Poster Presenter: Srijani Thannir

Thumbnail for Safety and Reliability of Isatuximab Subcutaneous On-Body Injector: Results Across the Phase 3 IRAKLIA, Phase 2 IZALCO and Phase 1b TCD15484 Trials

MM - 754

Safety and Reliability of Isatuximab Subcutaneous On-Body Injector: Results Across the Phase 3 IRAKLIA, Phase 2 IZALCO and Phase 1b TCD15484 Trials

Sloan Smith

Poster Presenter: Sloan Smith

Thumbnail for Second primary malignancies after CAR-T versus SCT in multiple myeloma

Previous 1...119 120 121 122 123 124 125...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MM - 757

Second primary malignancies after CAR-T versus SCT in multiple myeloma

Kirti Arora

Poster Presenter: Kirti Arora

Thumbnail for Secondary multiple myeloma and antecedent cancer lineage

MM - 762

Secondary multiple myeloma and antecedent cancer lineage

Kirti Arora

Poster Presenter: Kirti Arora

Thumbnail for Isatuximab-Carfilzomib-Dexamethasone Triplet Therapy: Real-World Data Based on the Hungarian Managed Access Program

MM - 766

Isatuximab-Carfilzomib-Dexamethasone Triplet Therapy: Real-World Data Based on the Hungarian Managed Access Program

Máté Huszár

Poster Presenter: Máté Huszár

$Thumbnail for Net Costs Associated With Inpatient Administration of Step-Up Dosing (SUD) of Bispecific Antibodies (bsAbs) Among Medicare Patients With Relapsed/Refractory Multiple Myeloma (MM)$

MM - 768

Net Costs Associated With Inpatient Administration of Step-Up Dosing (SUD) of Bispecific Antibodies (bsAbs) Among Medicare Patients With Relapsed/Refractory Multiple Myeloma (MM)

Timothy Inocencio

Poster Presenter: Timothy Inocencio

$Thumbnail for Ciltacabtagene Autoleucel in Lenalidomide-Refractory Multiple Myeloma Responding to Bridging Therapy: CARTITUDE-4 Cytogenetic Subgroup Analysis$

MM - 770

Ciltacabtagene Autoleucel in Lenalidomide-Refractory Multiple Myeloma Responding to Bridging Therapy: CARTITUDE-4 Cytogenetic Subgroup Analysis

Roberto Mina

Poster Presenter: Roberto Mina

$Thumbnail for Updated Results From the Phase 2 IZALCO Study: Efficacy and Safety of Isatuximab Subcutaneous Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma$

MM - 780

Updated Results From the Phase 2 IZALCO Study: Efficacy and Safety of Isatuximab Subcutaneous Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Wanda Vila-Carriles

Poster Presenter: Wanda Vila-Carriles

Thumbnail for Rising Venous Thromboembolism-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 1999-2024: Pulmonary Embolism Burden and Demographic Disparities

MM - 785

Rising Venous Thromboembolism-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 1999-2024: Pulmonary Embolism Burden and Demographic Disparities

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors